President Obama will leave office in less than six months, so Nature News has set out to explore what kind of legacy he leaves behind for such issues as climate change, biomedicine, scientific integrity, space research, and more.

Early in his administration, Obama overturned restrictions on research using embryonic stem cells and later launched initiatives to map the brain and cure cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.